PTAB Shuts Down Challenge To Gilead's Hep C Drug Patents
The Patent Trial and Appeal Board on Wednesday shot down the last of eight related requests filed by a nonprofit group focused on drug competition to review Gilead Pharmasset LLC's patents covering...To view the full article, register now.
Already a subscriber? Click here to view full article